FDA accepts Integral Molecular’s letter of intent (LOI) on Membrane Proteome Array antibody specificity test into ISTAND Drug Development Tools pilot program
PHILADELPHIA – Integral Molecular, the leader in antibody discovery against membrane proteins, has been accepted into the U.S. Food & ...